Reach Banner
Last name


Search Results to Manuel Carcao

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Carcao, Manuel

Item TypeName
Concept Granulocyte Colony-Stimulating Factor
Concept von Willebrand Factor
Concept Factor XIII Deficiency
Concept Factor VIIIa
Concept Factor IX
Concept Factor XIII
Concept Factor VIII
Concept Factor VIIa
Concept Factor VII
Concept Blood Coagulation Factor Inhibitors
Concept Factor VII Deficiency
Concept Factor XIIIa
Academic Article Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.
Academic Article Central venous catheter-related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors.
Academic Article Desmopressin (DDAVP) responsiveness in children with von Willebrand disease.
Academic Article Prophylactic factor replacement in hemophilia.
Academic Article Clostridium septicum myonecrosis in congenital neutropenia.
Academic Article Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
Academic Article Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia.
Academic Article Canadian multi-institutional survey of immune tolerance therapy (ITT) -- experience with the use of recombinant factor VIII for ITT.
Academic Article Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.
Academic Article Current and future approaches to inhibitor management and aversion.
Academic Article Application of current knowledge to the management of bleeding events during immune tolerance induction.
Academic Article Different clinical phenotype in triplets with haemophilia A.
Academic Article Intracranial bleeding in haemophilia beyond the neonatal period--the role of CT imaging in suspected intracranial bleeding.
Academic Article A comprehensive review of rFVIIa use in a tertiary care pediatric center.
Academic Article A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.
Academic Article On-label versus off-label use of recombinant activated factor VII: a comprehensive review of use in two Canadian centers.
Academic Article The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Academic Article Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
Academic Article Side-effects and venous access issues with immune tolerance therapy.
Academic Article Prophylaxis in haemophilia with inhibitors: update from international experience.
Academic Article Therapeutic consequences for misdiagnosis of type 2N von Willebrand disease.
Academic Article DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.
Academic Article Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand disease.
Academic Article Low prevalence of inhibitor antibodies in the Canadian haemophilia population.
Academic Article Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.
Academic Article Management of bleeding disorders in adults.
Academic Article Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Academic Article Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A.
Academic Article Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.
Academic Article Consequences of delayed therapy for sports-related bleeds in patients with mild-to-moderate haemophilia and type 3 von Willebrand's disease not on prophylaxis.
Academic Article Changing paradigm of prophylaxis with longer acting factor concentrates.
Academic Article A new era of therapy for congenital factor XIII deficiency.
Academic Article Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.
Academic Article Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.
Academic Article Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.
Academic Article Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.
Academic Article Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
Academic Article Switching from current factor VIII (FVIII) to longer acting FVIII concentrates--what is the real potential benefit?
Academic Article Individualizing factor replacement therapy in severe hemophilia.
Academic Article The role of previously untreated patient studies in understanding the development of FVIII inhibitors.
Academic Article Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitors.
Academic Article Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy.
Academic Article Factor VIII/factor IX prophylaxis for severe hemophilia.
Academic Article Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophilia.
Academic Article Nonacog beta pegol in previously treated children with hemophilia B: results from an international open-label phase 3 trial.
Academic Article Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.
Academic Article Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Academic Article Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
Academic Article Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A.
Academic Article Insight into health-related quality of life of young children with haemophilia B treated with long-acting nonacog beta pegol recombinant factor IX.
Academic Article Switching to extended half-life products in Canada - preliminary data.
Academic Article Desmopressin in moderate hemophilia A patients: a treatment worth considering.
Academic Article Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis.
Academic Article Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency.
Academic Article von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Academic Article DDAVP challenge tests in boys with mild/moderate haemophilia A.
Academic Article Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
Academic Article Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.
Academic Article Practical considerations in choosing a factor VIII prophylaxis regimen: Role of clinical phenotype and trough levels.
Academic Article A contemporary look at FVIII inhibitor development: still a great influence on the evolution of hemophilia therapies.
Academic Article Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.
Academic Article Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children.
Academic Article The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.
Academic Article Once-weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9-GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigmâ„¢ trials.
Academic Article Inhibitors: A Need for Eradication?
Academic Article Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?
Academic Article The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab.
Academic Article Hemophilia in a Changing Treatment Landscape.
Academic Article Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A.
Academic Article Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A.
Academic Article Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
Academic Article Measuring the impact of changing from standard half-life (SHL) to extended half-life (EHL) FVIII prophylaxis on health-related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO-KLAT tool.
Academic Article Long-Term Safety and Efficacy of Nonacog Beta Pegol (N9-GP) Administered for at Least 5 Years in Previously Treated Children with Hemophilia B.

Search criteria
  • Factor X